1. Cryptotanshinone (Dsh‐003) from Salvia miltiorrhiza Bunge inhibits prostaglandin E2‐induced survival and invasion effects in HA22T hepatocellular carcinoma cells
   Julia Huei‐Mei Chang et al, 2018, Environmental Toxicology CrossRef
2. Cyclooxygenase‐2 in gastrointestinal malignancies
   Ganji Purnachandra Nagaraju et al, 2019, Cancer CrossRef
3. Moringa oleifera Alkaloids Inhibited PC3 Cells Growth and Migration Through the COX-2 Mediated Wnt/β-Catenin Signaling Pathway
   Jing Xie et al, 2020, Frontiers in Pharmacology CrossRef
4. The Involvement ofβ-Catenin/COX-2/VEGF Axis in NMDA-Caused Retinopathy
   Dan Ning et al, 2017, Journal of Ophthalmology CrossRef
5. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma
   Yong-Jiang Xu et al, 2018, Cancer and Metastasis Reviews CrossRef
6. Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer
   David Jay Wilson et al, 2022, Cancer Prevention Research CrossRef
7. Grape Seed Proanthocyanidin Extract Inhibits Human Esophageal Squamous Cancerous Cell Line ECA109 via the NF-κB Signaling Pathway
   Fangming Guo et al, 2018, Mediators of Inflammation CrossRef
8. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
   Mario M. Alba et al, 2023, Frontiers in Physiology CrossRef
9. pH-Responsive nanoparticles based on ibuprofen prodrug as drug carriers for inhibition of primary tumor growth and metastasis
   Zhi Zeng et al, 2017, Journal of Materials Chemistry B CrossRef
10. Role of Meloxicam as a selective inhibitor of COX-2 in the inhibition of Ehrlich solid tumor growth
    Helena Jardim Constantino Dulce et al, 2017, African Journal of Pharmacy and Pharmacology CrossRef
11. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam
    Yun-Chu Chen et al, 2022, Journal of Controlled Release CrossRef
12. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
    Xinhe Zhang et al, 2021, Frontiers in Oncology CrossRef
13. miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway
    Zongyu Li et al, 2016, International Journal of Oncology CrossRef
14. Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke
    Changjun Yang et al, 2020, Frontiers in Neurology CrossRef
15. Casticin inhibits interleukin-1β-induced ICAM-1 and MUC5AC expression by blocking NF-κB, PI3K-Akt, and MAPK signaling in human lung epithelial cells
    Chian-Jiun Liou et al, 2017, Oncotarget CrossRef
16. Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma
    Filippo Pelizzaro et al, 2021, Clinical and Experimental Medicine CrossRef
17. Meloxicam Inhibited the Proliferation of LPS-Stimulated Bovine Endometrial Epithelial Cells Through Wnt/β-Catenin and PI3K/AKT Pathways
    Luying Cui et al, 2021, Frontiers in Veterinary Science CrossRef
18. Effects of LAIR‐1 on hepatocellular carcinoma cell proliferation and invasion via PI3K‐AKT‐mTOR pathway regulation
    Ti Zhou et al, 2023, Immunity, Inflammation and Disease CrossRef
19. The molecular mechanisms of celecoxib in tumor development
    Bin Wen et al, 2020, Medicine CrossRef
20. Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway
    Xiao Zhang et al, 2019, Cell Transplantation CrossRef
21. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway
    Hui Hua et al, 2018, Biomedicine & Pharmacotherapy CrossRef